Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Safety and efficacy of autologous, adipose-derived mesenchymal stem cells in patients with rheumatoid arthritis: a phase I/IIa, open-label, non-randomized pilot trial.
Stem Cell Res Ther. 2022 Mar 3;13(1):88. doi: 10.1186/s13287-022-02763-w.
Stem Cell Res Ther. 2022.
PMID: 35241141
Free PMC article.
Clinical Trial.
Frequency-dependent effect of intravenous administration of human adipose-derived mesenchymal stem cell therapy for severe Systemic Lupus Erythematosus: A case report.
Vij R, Tripathy M, Kim H, Park H, Cheng T, Lotfi D, Chang D.
Vij R, et al.
J Transl Autoimmun. 2022 Sep 23;5:100166. doi: 10.1016/j.jtauto.2022.100166. eCollection 2022.
J Transl Autoimmun. 2022.
PMID: 36187443
Free PMC article.
Item in Clipboard
Adipose-derived, autologous mesenchymal stem cell therapy for patients with post-COVID-19 syndrome: an intermediate-size expanded access program.
Vij R, Kim H, Park H, Cheng T, Lotfi D, Chang D.
Vij R, et al.
Stem Cell Res Ther. 2023 Oct 5;14(1):287. doi: 10.1186/s13287-023-03522-1.
Stem Cell Res Ther. 2023.
PMID: 37798650
Free PMC article.
Item in Clipboard
Cite
Cite